Published by Frank Prenesti on 13th April 2026
(Sharecast News) - GSK said its gynaecological cancer drug candidate had revealed positive results from early trials and would swiftly move to late-stage five clinical studies globally in the next few months.
URL: http://www.digitallook.com/dl/news/story/35846866/...